Intrinsic Value of S&P & Nasdaq Contact Us

Tenet Healthcare Corporation THC NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
69/100
3/7 Pass
SharesGrow Intrinsic Value
$535.37
+172.3%
Analyst Price Target
$258.55
+31.5%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Tenet Healthcare Corporation (THC) has shown moderate revenue growth over the past 3 years, expanding from $19.2B to $21.3B (average +3.6%/yr). Net income reached $1.4B, reflecting exceptional earnings expansion at +109.6%/yr on average. The net profit margin is 6.6%, which is moderate. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 41.4% (moderate), with a -41.5pp trend over the period. With a $17B market cap and MOAT composite score of 62/100, the company has a moderate competitive position.

Criteria proven by this page:

  • GROWTH (73/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 40-year history, the company was profitable in 28 of 40 years — a solid long-term record with occasional losses
  • INCOME (45/100, Partial) — the company is profitable but margin is below 15%
  • MOAT (62/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 69/100 with 3/7 criteria passed.

69/100
SG Score
View full scorecard →
~
VALUE
49/100
Price-to-Earnings & upside
→ IV page
FUTURE
85/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $15.49
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
62/100
Score: 62/100
GM 41.4% (-41.5pp)
Proven by this page
GROWTH
73/100
Rev +3.6%/yr
NI +109.6%/yr
Proven by this page
~
INCOME
45/100
Margin 6.6%
$21.3B
Proven by this page
Tenet Healthcare Corporation Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $21.31B$21.31B$20.67B$20.55B$19.17B
Gross Profit $12.82B$8.83B$11.86B$16.96B$15.9B
Gross Margin 60.2%41.4%57.4%82.5%82.9%
Operating Income $3.51B$3.51B$5.96B$2.51B$2.33B
Net Income $1.41B$1.41B$3.2B$611M$1B
Net Margin 6.6%6.6%15.5%3%5.2%
EPS (Diluted) $15.49$15.49$32.70$5.71$9.05
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message